Template:Prostatitis antibiotics: Difference between revisions
| Line 1: | Line 1: | ||
====Associated with STD==== | ====Associated with STD==== | ||
''Target organisms are [[E. coli]], and [[STDs]] ([[GC]])'' | ''Target organisms are [[E. coli]], and [[STDs]] ([[GC]])'' | ||
*[[Doxycycline]] 100mg PO q12 hrs x14 days + [[Ceftriaxone]] | *[[Doxycycline]] 100mg PO q12 hrs x14 days + [[Ceftriaxone]] 500mg IM x1 | ||
*[[Ciprofloxacin]] no longer recommended to treat gonorrhea in US | *[[Ciprofloxacin]] no longer recommended to treat gonorrhea in US | ||
Latest revision as of 12:10, 7 August 2023
Associated with STD
Target organisms are E. coli, and STDs (GC)
- Doxycycline 100mg PO q12 hrs x14 days + Ceftriaxone 500mg IM x1
- Ciprofloxacin no longer recommended to treat gonorrhea in US
No Associated STD and Chronic Bacterial Prostatitis
Aimed at Enterobacteriaceae, enterococci, Pseudomonas
- Ciprofloxacin 500mg PO q12hrs x 28 days OR
- Levofloxacin 500mg PO daily x 28 days OR
- TMP/SMX 1 DS tablet PO q12hrs x 28 days
- Consider extension to 6 wks of empiric therapy
Septic
- Gentamycin 7mg/kg IV daily + Ceftriaxone 1g IV q12hrs